Acrivon Therapeutics Stock (NASDAQ: ACRV) stock price, news, charts, stock research, profile.
Open | $8.320 |
Close | - |
Volume / Avg. | 74.962K / 781.654K |
Day Range | 8.150 - 8.900 |
52 Wk Range | 3.190 - 14.300 |
Market Cap | $260.589M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 8.77% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Acrivon Therapeutics (NASDAQ: ACRV) through any online brokerage.
Other companies in Acrivon Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP) and Agenus (NASDAQ:AGEN).
The latest price target for Acrivon Therapeutics (NASDAQ: ACRV) was reported by HC Wainwright & Co. on Tuesday, May 14, 2024. The analyst firm set a price target for 22.00 expecting ACRV to rise to within 12 months (a possible 164.11% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Acrivon Therapeutics (NASDAQ: ACRV) is $8.33 last updated Today at May 14, 2024 at 9:28 AM EDT.
There are no upcoming dividends for Acrivon Therapeutics.
Acrivon Therapeutics’s Q2 earnings are confirmed for Friday, August 9, 2024.
There is no upcoming split for Acrivon Therapeutics.
Acrivon Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.